Contract facts
FederalDEOBLIGATION OF FUNDS ON CLIN 3005AH is a federal award for W6qk Acc-Rsa held by Raytheon Company. Estimated value $297.9M ($-2,122.27 obligated). Current period of performance ends Jul 31, 2021. Place of performance: ANDOVER, MA.
Recompete timing
PublicCurrent PoP ended Jul 31, 2021 (1846 days ago). The usual 12–18 month agency planning window is closed — recompete action looks late / overdue relative to a normal cycle. Watch for bridge orders, follow-ons, or a new solicitation.
Incumbent footprint
Public recordRaytheon Company — $8.4B obligated across 383 awards (firm-wide, all agencies).
Related awards
Same parent · incumbentQuery this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W31P4Q20F0038?
W31P4Q20F0038 (Deobligation of FUNDS on CLIN 3005ah) is a W6qk Acc-Rsa award with an estimated value of $297.9M, currently held by Raytheon Company. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W31P4Q-20-F-0038?
W31P4Q-20-F-0038 is the dashed form of PIID W31P4Q20F0038 (Deobligation of FUNDS on CLIN 3005ah), held by Raytheon Company. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W31P4Q20F0038?
W6qk Acc-Rsa awarded W31P4Q20F0038 to Raytheon Company.
Who is the incumbent on W31P4Q20F0038?
Raytheon Company is the incumbent with $8.4B across 383 related awards in SCOUT’s public footprint. The current period of performance ends Jul 31, 2021.
When does Raytheon Company’s W31P4Q20F0038 come up for recompete?
SCOUT tracks a period-of-performance end of Jul 31, 2021. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.